Active — Not RecruitingEarly Phase 1

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

United States71 participantsStarted 2015-09-23

Plain-language summary

This trial studies the use of a special type of computed (CT) scan called dual energy CT in detecting gastrointestinal carcinoid tumors. CT is an imaging technique that uses x-rays and a computer to create images of areas inside the body. Dual energy computed tomography is a technique used during routine CT scans to help obtain and process the image after the scan is complete. Doctors want to learn if dual energy computed tomography can help improve the detection of carcinoid tumors during routine CT scans.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with: clinical features of carcinoid syndrome (or) increased serum and urinary markers suggestive of carcinoid (or) endoscopic biopsy proven carcinoid (or) metastases which are biopsy proven as carcinoid. * Patient is scheduled to have a clinically indicated staging CT exam. * Patients who have signed their informed consent form to undergo the study. Exclusion Criteria: * Patients who have already had their primary GI carcinoid resected. * Contraindication to intravenous contrast agents (e.g. allergy, renal failure, dialysis, pregnancy etc.). * Pregnant patients.

What they're measuring

Sensitivity and specificity of dual energy computed tomography in detecting primary gastrointestinal carcinoid tumors

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT04993261

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Carcinoid Syndrome trials